Please use this identifier to cite or link to this item:
                
    
    http://localhost:80/xmlui/handle/123456789/4553Full metadata record
| DC Field | Value | Language | 
|---|---|---|
| dc.date.accessioned | 2020-12-24T11:01:01Z | - | 
| dc.date.available | 2020-12-24T11:01:01Z | - | 
| dc.date.issued | 2019-03 | - | 
| dc.identifier.uri | http://172.16.0.4:8085/heritage/handle/123456789/4553 | - | 
| dc.language.iso | en_US | en_US | 
| dc.publisher | CSIR -N ational Institute of Science Communication And Information Resources, CSIR | en_US | 
| dc.relation.ispartofseries | VOL.58B;NUMBER 3 | - | 
| dc.subject | Indian Journal of Chemistry | en_US | 
| dc.subject | Enantiospecific syntheses of oxacyclodecanes from carvone via mild Lewis acid mediated etherifcation | en_US | 
| dc.subject | Facile enantiospecific syntheses of oxabicyclo- 14.4.0)decene-diones from carvone via mild Lewis acid mediated lactonizations | en_US | 
| dc.subject | Synthesis of new 4-substitued-l-(4-amino phenyl)- 5,6-dihydropyridine-2(lH)-one sulfonamide conjugates and evaluation of their anti-microbial activity | en_US | 
| dc.subject | Synthesis, QSRT studies and antibacterial activity of 4-aryl-3-chloro-l-(3,5-dimethyl-isoxazol-4-yl)- azetidin-2-ones | en_US | 
| dc.subject | In silico study for the prediction of multiple pharmacological activities of novel hydrazone derivatives | en_US | 
| dc.subject | Design of novel JNKI inhibitors using molecular modeling technique: An in silico approach | en_US | 
| dc.subject | Synthesis of a novel 2-vinyl indole | en_US | 
| dc.subject | Synthesis of (3-chloro-I-phenylsulfonylindol-2- ylmethyl) methylamine | en_US | 
| dc.title | Indian Journal of Chemistry | en_US | 
| dc.type | Image | en_US | 
| Appears in Collections: | Alerting of New Journals (Che and ENVS) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Indian Journal of Chemistry Section-B March 2019.pdf | 2.53 MB | Adobe PDF | View/Open | 
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.